Items where Author is "Vaheb, S."

(2026) Age-stratified clinical characteristics and disability outcomes in neuromyelitis optica spectrum disorder: A cross-sectional study. Acta neurologica Belgica. ISSN 2240-2993 (Electronic) 0300-9009 (Linking)

(2026) Associations between personality traits and cognitive function in multiple sclerosis and neuromyelitis optica spectrum disorder: A cross-sectional study. Multiple Sclerosis and Related Disorders. p. 8. ISSN 2211-0348

(2026) Bipolar disorder in people with multiple sclerosis: an updated systematic review and meta-analysis. Bmc Psychiatry. p. 13.

(2026) Bone Mineral Density Loss in Relapsing-remitting Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Matched Case-control Study. International Journal of Preventive Medicine. p. 9. ISSN 2008-7802

(2026) Choroid plexus volume in Alzheimer's disease: A systematic review and meta-analysis. Journal of Alzheimers Disease. pp. 53-64. ISSN 1387-2877

(2026) Cognitive function is associated with risk of conversion to secondary progressive multiple sclerosis: A cross-sectional study. Plos One. p. 17.

(2026) Cognitive performances in people with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 106921. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2026) Effects of binaural beats on acute stress recovery and autonomic regulation in multiple sclerosis: a pilot double-blind randomized controlled trial. Neurological Sciences. p. 13. ISSN 1590-1874

(2026) Fatigue and its contributing factors in people with multiple sclerosis: a cross-sectional study. Neurological research. pp. 555-567. ISSN 1743-1328 (Electronic) 0161-6412 (Linking)

(2026) Heart rate variability in people with multiple sclerosis: A systematic review and meta-analysis. Acta neurologica Belgica. pp. 67-83. ISSN 2240-2993 (Electronic) 0300-9009 (Linking)

(2026) Long-Term Clinical and Psychological Efficacy and Safety of Ocrelizumab in People With Multiple Sclerosis: A Real-World Longitudinal Study. Health Science Reports. p. 13.

(2026) Obsessive-compulsive disorder in people with multiple sclerosis: a systematic review and meta-analysis. Acta neurologica Belgica. ISSN 2240-2993 (Electronic) 0300-9009 (Linking)

(2026) Optical coherence tomography measurements between multiple sclerosis and neuromyelitis optica spectrum disorder: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 19. ISSN 2211-0348

(2026) Personality traits and disability in multiple sclerosis: The role of type D personality. Multiple Sclerosis and Related Disorders. p. 7. ISSN 2211-0348

(2026) Personality traits in people with multiple sclerosis: A systematic review and meta-analysis. The Clinical neuropsychologist. pp. 79-108. ISSN 1744-4144 (Electronic) 1385-4046 (Linking)

(2026) Prevalence and clinical correlates of obsessive-compulsive disorder in central nervous system autoimmune demyelinating diseases: A cross-sectional observational Study. Sage Open Chronic Disease. p. 10. ISSN 2755-8428

(2026) Prevalence and risk factors of bipolar disorder in central nervous system autoimmune demyelinating diseases. Bmc Psychiatry. p. 10.

(2026) Psychological correlates of suicidal ideation in people with multiple sclerosis: a cross-sectional study. Neurological research. pp. 1-16. ISSN 1743-1328 (Electronic) 0161-6412 (Linking)

(2026) Slowly Expanding Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Neurosci. p. 14.

(2026) Theory of Mind and Information Processing Speed in Multiple Sclerosis: Associations With Personality Traits. Brain and Behavior. p. 9. ISSN 2162-3279

(2026) Type 2 diabetes mellitus in people with multiple sclerosis: a systematic review and meta-analysis. Acta neurologica Belgica. ISSN 2240-2993 (Electronic) 0300-9009 (Linking)

(2026) Validation and interpretation of the Persian Multiple Sclerosis Neuropsychological Screening Questionnaire. Journal of clinical and experimental neuropsychology. pp. 1-11. ISSN 1744-411X (Electronic) 1380-3395 (Linking)

(2025) Association between diffusion tensor imaging measurements and cognitive performances in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 13. ISSN 2211-0348

(2025) Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis. Middle East Journal of Rehabilitation and Health Studies. ISSN 24234451 (ISSN)

(2025) Choroid plexus volume in multiple sclerosis: a systematic review and meta-analysis of an emerging imaging biomarker. European Journal of Medical Research. p. 16. ISSN 0949-2321

(2025) Clinical and psychological factors associated with fear of relapse in people with multiple sclerosis: A cross-sectional study. Journal of Clinical Neuroscience. p. 8. ISSN 0967-5868

(2025) Comorbidity and cardiovascular risk factors in multiple sclerosis. Multiple Sclerosis Journal-Experimental Translational and Clinical. p. 15.

(2025) Dementia in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis. Brain and Behavior. p. 12. ISSN 2162-3279

(2025) The Effects of OnabotulinumtoxinA Treatment for Spasticity inPatientsWithSpinal Cord Injury: ASystematic Review and Meta-analysis. Iranian Journal of Health Sciences. pp. 65-74. ISSN 2322553X (ISSN)

(2025) Frequency of tremor in people with multiple sclerosis: A systematic review and meta-analysis. Clinical parkinsonism & related disorders. p. 100315. ISSN 2590-1125 (Electronic) 2590-1125 (Linking)

(2025) Glymphatic system dysfunction in multiple sclerosis: A systematic review and meta-analysis. Magnetic Resonance Imaging. p. 9. ISSN 0730-725X

(2025) Gustatory dysfunction in multiple sclerosis: a systematic review and meta-analysis. Chemical Senses. p. 10. ISSN 0379-864X

(2025) Incidence of multiple sclerosis (MS) relapse after COVID-19 infection: A systematic review and meta-analysis. Caspian Journal of Internal Medicine. pp. 192-197. ISSN 2008-6164

(2025) Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis. International Journal of Preventive Medicine. p. 8. ISSN 2008-7802

(2025) Long-term effects of air pollution on the incidence and progression of multiple sclerosis: A population cohort study in Isfahan, Iran. Plos One. p. 17.

(2025) Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of Neurology. p. 25. ISSN 0340-5354

(2025) Onabotulinumtoxin intra-detrusor injection for lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Caspian Journal of Internal Medicine. pp. 588-598. ISSN 2008-6164

(2025) Optical coherence tomography angiography biomarkers in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review. International Journal of Retina and Vitreous. p. 10.

(2025) Prevalence and Odds of Cognitive Impairment in Multiple Sclerosis Subtypes and Neuromyelitis Optica Spectrum Disorder: A Case-Control Study. Advanced Biomedical Research. p. 6. ISSN 2277-9175

(2025) Sexual function and related predictors in male with multiple sclerosis and neuromyelitis optica spectrum disorder: a case-control study. The journal of sexual medicine. pp. 274-281. ISSN 1743-6109 (Electronic) 1743-6095 (Linking)

(2025) Sexual function in people with multiple sclerosis: a systematic review and meta-analysis. Journal of Sexual Medicine. pp. 1122-1138. ISSN 1743-6095

(2025) Suicide Ideation, Attempts, and Mortality in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Brain and Behavior. p. 17. ISSN 2162-3279

(2025) Timed 25-foot walk test is independently associated with cognitive function in multiple sclerosis: a cross-sectional study. European Journal of Medical Research. p. 299. ISSN 2047-783X (Electronic) 0949-2321 (Print) 0949-2321 (Linking)

(2025) Uveitis among people with multiple sclerosis: A systematic review and meta-analysis. Survey of Ophthalmology. pp. 331-338. ISSN 0039-6257

(2025) Validation and Interpretation of the Persian Version of the Swallowing Disturbance Questionnaire in Patients with Multiple Sclerosis. Neurosci. p. 13.

(2025) The association between information processing speed and clinical features in people with multiple sclerosis and neuromyelitis optica: a comparative study. Neurological Sciences. pp. 3783-3795. ISSN 1590-1874

(2025) The impact of physical and psychological health outcomes on stigma in people with neuromyelitis optica spectrum disorder: A cross-sectional study. Medicine. p. 8. ISSN 0025-7974

(2025) The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis. Neurologia. pp. 22-31. ISSN 0213-4853

(2025) The relationship between optical coherence tomography and magnetic resonance imaging measurements in people with multiple sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences. p. 9. ISSN 0022-510X

(2024) The Association of Salivary Cortisol Levels With Depression, Anxiety, and Quality of Life in Male Relapsing-Remitting Multiple Sclerosis Patients: A Case-Control Study. Acta Neurologica Scandinavica. p. 11. ISSN 0001-6314

(2024) Bone loss and fracture in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 11. ISSN 2211-0348

(2024) Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran. Plos One. p. 16. ISSN 1932-6203

(2024) Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders. Vaccine. p. 9. ISSN 0264-410X

(2024) Dysphagia in neuromyelitis optica spectrum disorder and multiple sclerosis: A comparison of frequency, severity, and effects on quality of life. Multiple Sclerosis and Related Disorders. p. 7. ISSN 2211-0348

(2024) Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of Neurology. p. 77. ISSN 1432-1459 (Electronic) 0340-5354 (Linking)

(2024) Multiple sclerosis and personality traits: associations with depression and anxiety. European Journal of Medical Research. p. 8. ISSN 0949-2321

(2024) Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): An updated systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 16. ISSN 2211-0348

(2024) Onabotulinum toxin A improves neurogenic detrusor overactivity following spinal cord injury: a systematic review and meta-analysis. Spinal Cord. pp. 285-294. ISSN 1362-4393

(2024) Prevalence and Outcome of COVID-19 Among Parkinson's Disease: A Report from Iran. Archives of Neuroscience. p. 8. ISSN 2322-3944

(2024) Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study. Multiple Sclerosis and Related Disorders. p. 8. ISSN 2211-0348

(2024) Psychosis and schizophrenia among patients with epilepsy: A systematic review and meta-analysis. Epilepsy Research. p. 20. ISSN 0920-1211

(2024) The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis. Medicina-Lithuania. p. 22. ISSN 1010-660X

(2024) Sexual function and related predictors in male with multiple sclerosis and neuromyelitis optica spectrum disorder: a case-control study. Journal of Sexual Medicine. pp. 274-281. ISSN 1743-6095

(2024) Validity and reliability of the Persian version of Recce stigma scale in people with multiple sclerosis and its impact on quality of life. Bmc Neurology. p. 9.

(2024) The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case-control study. European Journal of Medical Research. p. 11. ISSN 0949-2321

(2023) Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study. Current Journal of Neurology. pp. 82-86. ISSN 2717-011X

(2023) Fingolimod-induced bladder lymphoma in a patient with multiple sclerosis. Clinical Case Reports. p. 4. ISSN 2050-0904

(2023) Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review. Revue Neurologique. pp. 265-281. ISSN 0035-3787

(2023) Safety and efficacy of mesenchymal stem cell therapy in patients with multiple sclerosis during short- and long-term follow-up: a systematic review and meta-analysis. Multiple Sclerosis Journal. p. 1022. ISSN 1352-4585

(2023) Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic. Current Journal of Neurology. pp. 217-220. ISSN 2717-011X

(2023) Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis. Neurological Sciences. pp. 1905-1915. ISSN 1590-1874

(2022) Prevalence of trigeminal neuralgia in multiple sclerosis: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset. JOURNAL OF CLINICAL MEDICINE. ISSN 2077-0383 J9 - J CLIN MED

(2022) The prevalence of osteoporosis/osteopenia in patients with multiple sclerosis (MS): a systematic review and meta-analysis. NEUROLOGICAL SCIENCES. pp. 3879-3892. ISSN 1590-1874 1590-3478 J9 - NEUROL SCI

(2022) The prevalence of sexual dysfunction (SD) and erectile dysfunction (ED) in men with multiple sclerosis (MS): a systematic review and meta-analysis. Neurologia (Engl Ed). ISSN 2173-5808